About: Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus
Creator	Boeckh, Michael Ljungman, Per Einsele, Hermann Martino, Rodrigo Hirsch, Hans Ward, Katherine
Source	Medline; PMC
abstract	Community-acquired respiratory virus (CARV) infections have been recognized as a significant cause of morbidity and mortality in patients with leukemia and those undergoing hematopoietic stem cell transplantation (HSCT). Progression to lower respiratory tract infection with clinical and radiological signs of pneumonia and respiratory failure appears to depend on the intrinsic virulence of the specific CARV as well as factors specific to the patient, the underlying disease, and its treatment. To better define the current state of knowledge of CARVs in leukemia and HSCT patients, and to improve CARV diagnosis and management, a working group of the Fourth European Conference on Infections in Leukaemia (ECIL-4) 2011 reviewed the literature on CARVs, graded the available quality of evidence, and made recommendations according to the Infectious Diseases Society of America grading system. Owing to differences in screening, clinical presentation, and therapy for influenza and adenovirus, ECIL-4 recommendations are summarized for CARVs other than influenza and adenovirus.
has issue date	2013-01-15(xsd:dateTime)
bibo:doi	10.1093/cid/cis844
bibo:pmid	23024295
has license	cc-by
sha1sum (hex)	d009fdd48b7a8539c810eee5b108ca0fc6c5e6a8
schema:url	https://doi.org/10.1093/cid/cis844
resource representing a document's title	Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus
has PubMed Central identifier	PMC3526251
has PubMed identifier	23024295
schema:publication	Clin Infect Dis
resource representing a document's body	covid:d009fdd48b7a8539c810eee5b108ca0fc6c5e6a8#body_text
is schema:about of	named entity 'CORONAVIRUS' named entity 'INFECTIONS' named entity 'Diagnosis' named entity 'FOURTH' named entity 'EUROPEAN' named entity 'LEUKAEMIA' named entity 'METAPNEUMOVIRUS' named entity 'GUIDELINES ' named entity 'RHINOVIRUS' named entity 'PARAINFLUENZA VIRUS' named entity 'HUMAN RESPIRATORY SYNCYTIAL VIRUS' named entity 'FOR DIAGNOSIS' named entity 'TREATMENT' named entity 'CONFERENCE' named entity 'Rhinovirus' named entity 'Coronavirus' named entity 'paramyxo' named entity 'autologous' named entity 'lymphopenia' named entity 'aspirates' named entity 'antigen' named entity 'Corticosteroid' named entity 'bronchiolitis' named entity 'autologous' named entity 'picornaviruses' named entity 'histopathology' named entity 'immune dysfunction' named entity 'pediatric' named entity 'Parvoviridae' named entity 'HSCT' named entity 'chemotherapy' named entity 'HSCT' named entity 'clinical outcome' named entity 'protein' named entity 'polymerase chain reaction' named entity 'lymphopenia' named entity 'HPIV' named entity 'leukemia' named entity 'RSV' named entity 'Laboratory tests' named entity 'RSV' named entity 'morbidity' named entity '2.1' named entity 'polyomaviruses' named entity 'ribavirin' named entity 'randomized controlled clinical trials' named entity 'risk factors' named entity 'antivirals' named entity 'small interfering RNA' named entity 'morbidity' named entity 'flu-like symptoms' named entity 'aspirates' named entity 'HSCT' named entity 'temperate climates' named entity 'picornavirus' named entity 'monoclonal antibody' named entity 'replicating viruses' named entity 'coinfections' named entity 'HSCT' named entity 'clinical outcome' named entity 'myeloablative' named entity 'RSV' named entity 'disseminated disease' named entity 'larynx' named entity 'allogeneic' named entity 'infection control' named entity 'PubMed' named entity 'leukemia' named entity 'palivizumab' named entity 'sinusitis' named entity 'influenza' named entity 'polyomavirus' named entity 'asymptomatic' named entity 'HSCT' named entity 'lymphocyte' named entity 'pharyngitis'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software